Evidence map›Paper›PMID 37568656›Full record

ArticleCancers2023

Recurrence of Basal Cell Carcinoma Treated with Surgical Excision and Histopathological Analysis with Frozen Section Technique with Complete Margin Control (CMC-FS): A 15-Year Experience of a Reference Center.

Alessandra Di Maria, Gianmaria Barone, Vanessa Ferraro, Costanza Tredici, Sofia Manara, Camilla De Carlo, Alessandro Gaeta, Filippo Confalonieri

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Alessandra Di MariaDepartment of Ophthalmology, IRCCS Humanitas Research Hospital, 20089 Milan, Italy.ORCID 0000-0002-4889-6315
Gianmaria BaroneDepartment of Ophthalmology, IRCCS Humanitas Research Hospital, 20089 Milan, Italy.
Vanessa FerraroDepartment of Ophthalmology, IRCCS Humanitas Research Hospital, 20089 Milan, Italy.
Costanza TrediciDepartment of Ophthalmology, IRCCS Humanitas Research Hospital, 20089 Milan, Italy.
Sofia ManaraDepartment of Biomedical Sciences, Humanitas University, 20090 Milan, Italy.
Camilla De CarloDepartment of Biomedical Sciences, Humanitas University, 20090 Milan, Italy.
Alessandro GaetaDepartment of Internal Medicine and Medical Specialties (DIMI), Università di Genova, 16132 Genova, Italy.ORCID 0000-0002-8714-4052
Filippo ConfalonieriDepartment of Ophthalmology, IRCCS Humanitas Research Hospital, 20089 Milan, Italy.ORCID 0000-0003-4079-8881
Humanitas University · ITUniversity of Genoa · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBasal cell carcinoma (BCC) is the most common type of eyelid malignancy and it is considered to be dangerous due to its proximity to functionally essential organs. Early diagnosis and complete excision of the primary lesion are crucial to prevent infiltration and metastasis. The study aims to evaluate the extent of recurrence in subjects affected by BCC of the upper third of the face treated with surgical eradication and the frozen section technique with complete margin control (CMC-FS), in comparison with the gold standard Mohs micrographic surgery (MMS). MATERIALS AND

methodsThe study included 111 patients with 111 biopsy-proven eyelid BCCs. On clinical examination, all lesions were removed with 2 mm margins clinically free of neoplasm. Prior to reconstruction, CMC-FS analysis of all surgical margins was performed on each tumor for histopathologic confirmation. Subsequently, all margins were presented for the permanent paraffin sections.

resultsThere were 69 primary carcinomas and 42 secondary carcinomas among the 111 samples. No recurrence occurred in 109 tumors followed-up for at least 5 years, with a total recurrence rate of 1.8%. The median time between lesion excision and diagnosis of recurrence was 20 months.

conclusionsat 5-year follow-up, CMC-FS guided excision of BCCs of the eyelids resulted in recurrence rates equivalent to MMS. Intraoperative microscopic control of all margins reduced the recurrence rate of the upper third of the facial BCCs, correlating with easier reconstruction with better esthetic and functional outcome.

Indexed as

basal cell carcinomaCMC-FS frozen section analysiscontrolled excision via frozen sectioneyelid carcinomarecurrent basal cell carcinoma

Identifiers

PMID37568656
PMCPMC10417263
OpenAlexW4385342176

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.